Next-Gen mRNA & Oncology: 2026 FDA Deadline Approaches
Next-gen mRNA oncology faces August 2026 FDA deadline.
Next-Gen mRNA & Oncology: 2026 FDA Deadline Approaches Read Post »
Foundayo Approval: Oral GLP-1 Obesity Paradigm Shift
Foundayo’s oral GLP-1 approval shifts obesity paradigm.
Foundayo Approval: Oral GLP-1 Obesity Paradigm Shift Read Post »
FDA Approves First Gene Therapy for Severe LAD-I
FDA approves autologous gene therapy for severe LAD-I.
FDA Approves First Gene Therapy for Severe LAD-I Read Post »
FDA Approves Foundayo: First NME Under National Priority Voucher
Foundayo approved: Fastest NME via priority voucher program.
FDA Approves Foundayo: First NME Under National Priority Voucher Read Post »
2026 mRNA Cancer Vaccine Breakthroughs: Clinical & Regulatory Outlook
mRNA cancer vaccines: promising clinical & regulatory future.
2026 mRNA Cancer Vaccine Breakthroughs: Clinical & Regulatory Outlook Read Post »